Literature DB >> 20527688

Risk factors. Oncotype DX assay predicts local recurrence in breast cancer.

Rebecca Kirk.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20527688     DOI： 10.1038/nrclinonc.2010.75

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.

Authors:  Eleftherios P Mamounas; Gong Tang; Bernard Fisher; Soonmyung Paik; Steven Shak; Joseph P Costantino; Drew Watson; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544
  1 in total
  4 in total

Review 1.  Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.

Authors:  Russell M Medford; T Forcht Dagi; Robert S Rosenson; Margaret K Offermann
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

Review 2.  Predictive models for the practical management of renal cell carcinoma.

Authors:  Lui Shiong Lee; Min-Han Tan
Journal:  Nat Rev Urol       Date:  2012-01-10       Impact factor: 14.432

3.  The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.

Authors:  Nikhil G Thaker; Karen E Hoffman; Michael C Stauder; Simona F Shaitelman; Eric A Strom; Welela Tereffe; Benjamin D Smith; George H Perkins; Lei Huo; Mark F Munsell; Lajos Pusztai; Thomas A Buchholz; Wendy A Woodward
Journal:  Springerplus       Date:  2015-01-30

Review 4.  Understanding breast cancer - The long and winding road.

Authors:  Kiven Erique Lukong
Journal:  BBA Clin       Date:  2017-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.